Home
FBIO
FBIO News

Latest Fortress Biotech Inc. (FBIO) News on July 27, 2024

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

GlobeNewswire

a day ago

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

GlobeNewswire

2 days ago

Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

Argus Research

11 days ago

Daily – Vickers Top Buyers & Sellers for 07/16/2024

Here Is Why Bargain Hunters Would Love Fast-paced Mover Fortress Biotech (FBIO)

Zacks

11 days ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover Fortress Biotech (FBIO)

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

GlobeNewswire

12 days ago

GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

GlobeNewswire

15 days ago

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

GlobeNewswire

21 days ago

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

25 days ago

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab

GlobeNewswire

25 days ago

Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission

GlobeNewswire

a month ago

Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a month ago

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

GlobeNewswire

a month ago

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

a month ago

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy

GlobeNewswire

a month ago

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

GlobeNewswire

2 months ago

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GlobeNewswire

2 months ago

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

Associated Press Finance

2 months ago

Fortress Biotech: Q1 Earnings Snapshot

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 months ago

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

GlobeNewswire

2 months ago

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates

Zacks

2 months ago

AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates

Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 months ago

Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

MT Newswires

2 months ago

Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

GlobeNewswire

2 months ago

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

2 months ago

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire

2 months ago

Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

GlobeNewswire

3 months ago

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

GlobeNewswire

3 months ago

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Mustang Bio Announces Closing of $4 Million Public Offering

GlobeNewswire

3 months ago

Mustang Bio Announces Closing of $4 Million Public Offering

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

GlobeNewswire

3 months ago

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

Mustang Bio Announces Pricing of $4 Million Public Offering

GlobeNewswire

3 months ago

Mustang Bio Announces Pricing of $4 Million Public Offering

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

GlobeNewswire

3 months ago

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

GlobeNewswire

3 months ago

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

Avenue Therapeutics Announces Reverse Stock Split

GlobeNewswire

3 months ago

Avenue Therapeutics Announces Reverse Stock Split

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

GlobeNewswire

4 months ago

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

GlobeNewswire

4 months ago

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

GlobeNewswire

4 months ago

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

GlobeNewswire

4 months ago

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors

GlobeNewswire

4 months ago

Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

GlobeNewswire

4 months ago

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

GlobeNewswire

4 months ago

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

GlobeNewswire

4 months ago

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

Fortress Biotech to Participate in 36th Annual ROTH Conference

GlobeNewswire

4 months ago

Fortress Biotech to Participate in 36th Annual ROTH Conference

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

GlobeNewswire

5 months ago

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

GlobeNewswire

5 months ago

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

GlobeNewswire

5 months ago

Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

GlobeNewswire

5 months ago

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

GlobeNewswire

5 months ago

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

Insider Stock Buying Reaches US$3.06m On Fortress Biotech

Simply Wall St.

5 months ago

Insider Stock Buying Reaches US$3.06m On Fortress Biotech

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

News Direct

6 months ago

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Invesco Closed-End Funds Pay Dividends

PR Newswire

6 months ago

Invesco Closed-End Funds Pay Dividends

Alarum: NetNut Enhances Data Collection Offering - Launching its Second Innovative Product

GlobeNewswire

6 months ago

Alarum: NetNut Enhances Data Collection Offering - Launching its Second Innovative Product

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire

6 months ago

Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market

Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List

GlobeNewswire

6 months ago

Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List

Mega Matrix Announces FlexTV’S Surge Into Top Ten Free Iphone Entertainment Apps (U.S.) as of JAN. 21, 2024

GlobeNewswire

6 months ago

Mega Matrix Announces FlexTV’S Surge Into Top Ten Free Iphone Entertainment Apps (U.S.) as of JAN. 21, 2024

Alarum Technologies Ltd. Featured in Syndicated Broadcast Covering Preliminary Q4 2023 Results Pointing Towards All Time High Operating Cashflow and Revenue

GlobeNewswire

6 months ago

Alarum Technologies Ltd. Featured in Syndicated Broadcast Covering Preliminary Q4 2023 Results Pointing Towards All Time High Operating Cashflow and Revenue

DZS Extends Partnership with Andorix to Transform the Infrastructure and Commercial Management Economics of Historical Landmarks

GlobeNewswire

6 months ago

DZS Extends Partnership with Andorix to Transform the Infrastructure and Commercial Management Economics of Historical Landmarks

TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million

PR Newswire

6 months ago

TAT Technologies signs another 5-year contract with an international air carrier for APU MRO services with estimated total revenues of $10 million

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

GlobeNewswire

6 months ago

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

GlobeNewswire

6 months ago

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

GlobeNewswire

6 months ago

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

Investors in InterGroup (NASDAQ:INTG) from a year ago are still down 51%, even after 16% gain this past week

Simply Wall St.

7 months ago

Investors in InterGroup (NASDAQ:INTG) from a year ago are still down 51%, even after 16% gain this past week

Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...

GuruFocus.com

7 months ago

Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...

Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

GlobeNewswire

7 months ago

Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

GlobeNewswire

7 months ago

Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

GlobeNewswire

7 months ago

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition

InvestorPlace

7 months ago

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition

11 Cheap Pot Stocks to Buy

Insider Monkey

7 months ago

11 Cheap Pot Stocks to Buy

2024 election: $16B expected to be spent on political ads

Yahoo Finance Video

7 months ago

2024 election: $16B expected to be spent on political ads

TAT Technologies completed Private Placement to Israeli Institutional and Accredited Investors

PR Newswire

7 months ago

TAT Technologies completed Private Placement to Israeli Institutional and Accredited Investors

Investors in TAT Technologies (NASDAQ:TATT) have seen strong returns of 131% over the past three years

Simply Wall St.

7 months ago

Investors in TAT Technologies (NASDAQ:TATT) have seen strong returns of 131% over the past three years

Westport (WPRT) Gets $33M Contract From Truck Manufacturer

Zacks

7 months ago

Westport (WPRT) Gets $33M Contract From Truck Manufacturer

Alarum: NetNut's SERP Scraper API Gains Momentum with the Onboarding of Several New Customers

GlobeNewswire

7 months ago

Alarum: NetNut's SERP Scraper API Gains Momentum with the Onboarding of Several New Customers

reAlpha to Acquire United Software Group to Boost AI Capabilities

Exec Edge

7 months ago

reAlpha to Acquire United Software Group to Boost AI Capabilities

Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board

GlobeNewswire

7 months ago

Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board

PR Newswire

7 months ago

TAT Technologies Announces Proposed Private Placement to Israeli Institutional and Accredited Investors

David Einhorn's Greenlight Capital Boosts Coya Therapeutics Holding

GuruFocus.com

7 months ago

David Einhorn's Greenlight Capital Boosts Coya Therapeutics Holding

Travelzoo Introduces Membership Fee for New Members Beginning January 1, 2024

PR Newswire

7 months ago

Travelzoo Introduces Membership Fee for New Members Beginning January 1, 2024

NetNut Targeting the $2.22 billion Market of Data Collection with Cutting-Edge SERP Scraper API

GlobeNewswire

7 months ago

NetNut Targeting the $2.22 billion Market of Data Collection with Cutting-Edge SERP Scraper API

PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders

PR Newswire

8 months ago

PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders

AstroNova, Inc. (NASDAQ:ALOT) Q3 2024 Earnings Call Transcript

Insider Monkey

8 months ago

AstroNova, Inc. (NASDAQ:ALOT) Q3 2024 Earnings Call Transcript

3 Vulnerable Retail Stocks That Won’t Survive the Holidays

InvestorPlace

8 months ago

3 Vulnerable Retail Stocks That Won’t Survive the Holidays

Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress

GlobeNewswire

8 months ago

Cidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress

Ceragon Networks Completes Acquisition of Siklu

PR Newswire

8 months ago

Ceragon Networks Completes Acquisition of Siklu

PR Newswire

8 months ago

NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces Distributions

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

PR Newswire

8 months ago

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

PR Newswire

8 months ago

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

TAT Technologies Ltd.'s (NASDAQ:TATT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Simply Wall St.

8 months ago

TAT Technologies Ltd.'s (NASDAQ:TATT) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Alarum Transitioned to Net Profit of $1.1 Million in The Third Quarter of 2023; Adjusted EBITDA Climbed to a Record of $1.9 Million

GlobeNewswire

8 months ago

Alarum Transitioned to Net Profit of $1.1 Million in The Third Quarter of 2023; Adjusted EBITDA Climbed to a Record of $1.9 Million

Investors in Profire Energy (NASDAQ:PFIE) have seen favorable returns of 90% over the past three years

Simply Wall St.

8 months ago

Investors in Profire Energy (NASDAQ:PFIE) have seen favorable returns of 90% over the past three years

Share on Social Networks: